Skip to content

Faculty

$2.5M Grant Will Help Professor to Build a Powerful Molecular Imaging Scanner

Bioengineering Professor Changqing Li was recently awarded a four-year, $2.5 million R01 grant from the National Institutes of Health (NIH) to help develop a focused X-ray luminescence tomography (FXLT) scanner that could accelerate cancer research.

The scanner is a first-of-its kind molecular imaging tool that will allow researchers to visualize how disease progresses and monitor the effectiveness of novel drug-delivery systems in live animals — without invasive surgeries or euthanizing the animals.

Multimillion-Dollar Grant Brings Nicotine and Cannabis Policy Center to Campus

UC Merced has been awarded a $3.8 million grant to establish the UC Nicotine and Cannabis Policy Center (NCPC), positioning UC Merced and the San Joaquin Valley region as a leading center for the study of public health and policy matters related to tobacco and marijuana.

“Awarding of this center grant to UC Merced and its partners is a clear sign of the commitment, expertise and leadership of our faculty in addressing issues critical to both the Valley and the world,” Vice Chancellor for Research and Economic Development Sam Traina said.

Dr. Fabian Filipp Identifies Master Regulators and New Drug Targets in Therapy-Resistant Cancer

New research published today in the Nature Partner journal npj Systems Biology and Applications establishes how genome-wide data in combination with systems biology analyses can identify master regulators and new drug targets in therapy-resistant cancers.

The new discovery explains how cancer controls specific effector networks — findings with important implications for the future of cancer therapy.

Misbehaving “Killer” Cells Accelerate Progress of Autoimmune Disease

In 1998, scientists studying rheumatoid arthritis observed a population of immune cells that weren’t behaving the way they were supposed to. Immunologists noted the strange phenomenon, but decided not to pursue the subject further, and the cells were soon forgotten.

But interest in these cells has swelled over the past few years as they’ve been found in patients with chronic viral infections and cancer.

Pages